Influenza is one of the most important respiratory diseases of mankind, yet scant data exist concerning the frequency and clinical course of influenza in severely immunocompromised adults. From October 1993 to September 1994, we cultured the respiratory secretions of all adults with leukemia who were hospitalized with an acute respiratory illness at The University of Texas M.D. Anderson Cancer Center in Houston. During a 9-week period from 29 November 1993 to 29 January 1994, influenza virus type A (H3N2) was isolated from 15 (33%) of these 45 hospitalized adults. Twelve (80%) of the cases of influenza were associated with pneumonia, and four patients (33%) with pneumonia died. Patients who died tended to have received chemotherapy more recently and to be more myelosuppressed. Autopsy examination in two cases revealed histopathologic changes consistent with viral pneumonia. During community outbreaks, influenza is a frequent cause of serious respiratory disease in hospitalized adults with leukemia. Effective prophylactic and therapeutic regimens need to be defined for immunocompromised patients.
Influenza is one of the most important respiratory diseases acute respiratory illness. Cultures were performed either at the time of admission or during the hospitalization, depending on of mankind. Epidemics of influenza occur nearly annually and are associated with considerable morbidity and mortality when the respiratory illness developed. Most specimens consisted of combined nasopharyngeal wash [1 -3] . Although immunocompromised patients are considered to be at high risk for developing serious pulmonary complicaand throat swab samples. When available, endotracheal aspirates and bronchoalveolar lavage fluids were cultured as well. tions, only scant data exist delineating the actual frequency and morbidity and mortality of influenza in adults with cancer
The medical records and chest radiographs of patients from whom influenza virus was isolated were reviewed. Only cul- [4 -8] . To describe the frequency and clinical course of influenza in a subset of severely immunocompromised adults, we ture-confirmed cases were included in the analysis. prospectively followed all adults with leukemia who were hospitalized at The University of Texas M.D. Anderson Cancer
Definitions
Center (MDACC; Houston) during a 1-year period.
An acute respiratory illness was defined as the recent onset (within £14 days) of rhinorrhea, nasal and sinus congestion, Methods pharyngitis, coryza, sinusitis, otitis media, cough, and/or a new radiographic pulmonary infiltrate. Fever alone was not an indi-
Study Design
cation for performing a respiratory viral culture. Pneumonia From 1 October 1993 through 30 September 1994, all adults was defined as an acute respiratory illness occurring in associawith leukemia who were hospitalized at MDACC were tion with a new radiographic infiltrate. screened daily for signs and symptoms of a respiratory illness.
A patient was considered to have received therapy for influRespiratory secretions were sampled from all patients with an enza if amantadine, rimantadine, and/or ribavirin was administered for at least 48 hours following the onset of symptoms. All patients also received broad-spectrum antibiotics. As a conservative estimate, an infection was considered to be nosoco- 
Results
Myalgia 4 (27) Chest pain 1 (7) Sixteen cases of influenza were identified during the 1-year Pneumonia 12 (80) surveillance period. All isolates were of type A (H3N2). Fifteen Death 4 (27) cases occurred during an 9-week period from 29 November 1993 to 29 January 1994, in the midst of a community outbreak 9-week outbreak, 45 adults with leukemia were hospitalized at MDACC with an acute respiratory illness, all of whom had respiratory secretions sampled for viral culture. Thus, the freFour (33%) of the 12 patients with pneumonia died of proquency of influenza was 33% (15 of 45) among adults with gressive respiratory failure at a mean of 24 days (range, 8 -31 leukemia who were hospitalized with an acute respiratory illdays) after the onset of symptoms. Two of these four patients ness. Two infections (13%) were acquired nosocomially.
had concurrent pulmonary infections: one had RSV and canThe demographic and clinical characteristics of these 15 didal infection and the other had RSV infection. Autopsies patients are shown in table 1. None of the patients had received were performed on these two patients and revealed changes either vaccination or chemoprophylaxis for influenza. Older consistent with viral pneumonia, including diffuse alveolar adults did not have a higher frequency of pulmonary complicadamage, intracytoplasmic inclusions, and syncytial cells. One tions or death than did younger adults. The most common patient also had lobar candidal pneumonia. presenting symptom was fever, followed in frequency by cough
Although not statistically significant, there was a tendency and wheezing.
toward a higher frequency of pulmonary complications and Eight patients (53%) complained of nasal congestion. Two death among patients who had more recently received chemoof five patients evaluated had radiographically documented sitherapy and who had more chemotherapy-induced myelosupnusitis, one of whom had concurrent aspergillas sinusitis. Only pression. Thus, patients with pulmonary complications develfive patients (33%) complained of sore throat; however, in oped symptoms at a mean of 9 days (median, 9 days) after some cases this complaint may have been overshadowed by receiving chemotherapy, compared with a mean of 36 days painful chemotherapy-induced mucositis. In 12 (80%) of the (median, 20 days) for patients without pulmonary complica-15 patients with influenza, the illness was complicated by pneutions. monia.
Patients who died developed symptoms at a mean of 5 days Pneumonia was documented a mean of 8 days (range, 0 -24 (median, 6 days) after receiving chemotherapy, compared with days) after the onset of symptoms. Chest radiographs revealed 18 days (median, 10 days) for patients who survived. Similarly, unilateral infiltrates in two patients and bilateral infiltrates in pneumonia developed in 9 (90%) of 10 patients who developed 10 patients. Concurrent pulmonary infections were identified in symptoms within 14 days of receiving chemotherapy, vs. 3 3 patients (25%) with pneumonia; these were due to Aspergillus (60%) of 5 patients who developed symptoms ú14 days after species, respiratory syncytial virus (RSV), and combined RSV receiving chemotherapy. and Candida species, respectively. All 12 patients were treated
Although the majority of patients were neutropenic at the onset of the illness, patients who died tended to have more with broad-spectrum antibiotics.
/ 9c2f$$ju31
05-07-97 17:31:04 cida UC: CID persisting neutropenia. Three (75%) of four patients who died the United States, and 99% of the isolates were of influenza type A (H3N2) [25] . were neutropenic at the onset of the illness, and all three patients remained neutropenic 2 weeks later. In contrast, 7 (64%)
Coupled with this high infection rate was a high rate of pulmonary complications. Eighty percent of these infections of 11 patients who survived were neutropenic at the onset, and only 3 patients (27%) remained neutropenic 2 weeks later.
were complicated by pneumonia, and the associated mortality of 33% was also high. The risk of developing pneumonia and With regard to lymphopenia, 1 (25%) of 4 patients who died was lymphopenic at the onset of the illness, and 2 of the 4 the mortality tended to be higher among patients who had more recently received chemotherapy and who were therefore more were lymphopenic 2 weeks later. In contrast, 6 (55%) of 11 patients who survived were lymphopenic at the onset, and 3 myelosuppressed; however, less-myelosuppressed patients were also at risk. (27%) remained lymphopenic 2 weeks later.
Nine patients (including 8 with pneumonia) were treated A more clear-cut increased risk of pneumonia and death for patients with chemotherapy-induced myelosuppression has for influenza for a mean of 12 days (range, 6 -29 days) with amantadine (n Å 3), rimantadine (n Å 4), aerosolized ribavirin been demonstrated with regard to another community respiratory virus, RSV [15 -18, 24] . The role of the various compo-(n Å 1), and rimantadine and aerosolized ribavirin (n Å 1). The length of time between the onset of illness and the initiation nents of the host defense system, such as neutrophils and humoral and cell-mediated immunity, in the pathogenesis of lower of therapy tended to be longer among patients who died (mean, 13 days; median, 11 days) than among patients who survived respiratory tract disease due to the community respiratory viruses is poorly understood and needs to be studied. (mean, 8 days; median, 7 days), although the difference was not statistically significant.
Surprisingly scant data exist regarding the frequency and morbidity and mortality of influenza virus infections in severely Among the 15 patients, the initial isolate of influenza virus was from combined nasopharyngeal wash and throat swab immunocompromised adults with cancer. Two previous studies involving 28 adult bone marrow transplant (BMT) recipients specimens from 12, endotracheal aspirates from 2, and bronchoalveolar lavage fluid from 1. During the course of the illand 37 adults with leukemia who were hospitalized at MDACC with an acute respiratory illness during the 1991 -1992 communess, influenza virus was isolated from a bronchoalveolar lavage or endotracheal aspirate from four of the seven patients nity epidemic of influenza also documented a high frequency of influenza: 29% and 11%, respectively [7, 8] . The frequency who had such samples obtained. Virus was shed for a mean of 3.5 days (range, 1 -23 days); however, follow-up cultures of pulmonary complications was also high: 6 (75%) of the 8 BMT recipients and 3 (75%) of the 4 leukemia patients with were not performed systematically.
influenza developed pneumonia, with an associated mortality of 17% and 33%, respectively. The high frequency and morbidity and mortality observed Discussion in these studies and in the current study of severely immunocompromised patients are in contrast with the generally mild, Viral pneumonia in the immunocompromised adult has traditionally been attributed primarily to the herpesviruses, particuself-limited disease observed in a study of 25 ''immunocompromised'' patients in Stockholm [6] . In that study, only three larly cytomegalovirus [10, 11] . Over the past decade, there has been a growing recognition that community respiratory viruses patients (12%) developed pneumonia, and only one patient died (a BMT recipient with aplastic marrow). This wide spectrum such as RSV, parainfluenza virus, and adenovirus are a frequent cause of serious respiratory disease among immunocomproof observations probably reflects the wide spectrum of immunocompromised patients being evaluated. The majority of the mised adults [12 -24] . This study highlights the importance of influenza, a potentially preventable community respiratory patients in the Stockholm study were considerably less ''immunocompromised'' than BMT recipients and patients with leukeinfection, in adults with leukemia.
During the wintertime community outbreak, one-third of the mia. In less immunocompromised patients, the clinical course of influenza may be more comparable to that in immunocompeadults with leukemia who were hospitalized with an acute respiratory illness were documented by culture to be infected with tent persons. Pneumonia complicating influenza is frequently of bacterial influenza virus. This is a minimum estimate of the frequency of influenza, since the study did not include clinically or seroor mixed viral/bacterial origin [3] . Since all surviving patients in our study were treated with broad-spectrum antibiotics, and logically confirmed cases and respiratory viral cultures were not performed for patients who presented with fever alone or since these patients did not have lung tissue sampled for histopathology, it was not always clear whether these patients had nonrespiratory illnesses. Furthermore, the study included all patients with a respiratory illness of £14 days' duration, some primary influenza virus pneumonia and/or secondary pneumonia due to other microorganisms. of whom may have already ceased shedding virus when their respiratory secretions were sampled. In the Houston community
In the two fatal cases in which lung tissue was available for review, histopathology revealed changes consistent with viral that year, the influenza epidemic was moderately severe (personal communication, P. W. Glezen), as it was in the rest of pneumonia, suggesting that influenza played a significant role / 9c2f$$ju31 05-07-97 17:31:04 cida UC: CID in these pneumonias; however, RSV was also isolated from globally beneficial since influenza is such an important cause of serious respiratory disease in the general community. both patients before death and may have contributed to the pathology.
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